Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
- PMID: 21127304
- DOI: 10.1161/STR.0b013e3181fcb238
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
Erratum in
- Stroke. 2011 Feb;42(2):e26
Abstract
Background and purpose: This guideline provides an overview of the evidence on established and emerging risk factors for stroke to provide evidence-based recommendations for the reduction of risk of a first stroke.
Methods: Writing group members were nominated by the committee chair on the basis of their previous work in relevant topic areas and were approved by the American Heart Association (AHA) Stroke Council Scientific Statement Oversight Committee and the AHA Manuscript Oversight Committee. The writing group used systematic literature reviews (covering the time since the last review was published in 2006 up to April 2009), reference to previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate recommendations using standard AHA criteria (Tables 1 and 2). All members of the writing group had the opportunity to comment on the recommendations and approved the final version of this document. The guideline underwent extensive peer review by the Stroke Council leadership and the AHA scientific statements oversight committees before consideration and approval by the AHA Science Advisory and Coordinating Committee.
Results: Schemes for assessing a person's risk of a first stroke were evaluated. Risk factors or risk markers for a first stroke were classified according to potential for modification (nonmodifiable, modifiable, or potentially modifiable) and strength of evidence (well documented or less well documented). Nonmodifiable risk factors include age, sex, low birth weight, race/ethnicity, and genetic predisposition. Well-documented and modifiable risk factors include hypertension, exposure to cigarette smoke, diabetes, atrial fibrillation and certain other cardiac conditions, dyslipidemia, carotid artery stenosis, sickle cell disease, postmenopausal hormone therapy, poor diet, physical inactivity, and obesity and body fat distribution. Less well-documented or potentially modifiable risk factors include the metabolic syndrome, excessive alcohol consumption, drug abuse, use of oral contraceptives, sleep-disordered breathing, migraine, hyperhomocysteinemia, elevated lipoprotein(a), hypercoagulability, inflammation, and infection. Data on the use of aspirin for primary stroke prevention are reviewed.
Conclusions: Extensive evidence identifies a variety of specific factors that increase the risk of a first stroke and that provide strategies for reducing that risk.
Similar articles
-
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.Stroke. 2006 Jun;37(6):1583-633. doi: 10.1161/01.STR.0000223048.70103.F1. Epub 2006 May 4. Stroke. 2006. PMID: 16675728
-
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.Circulation. 2006 Jun 20;113(24):e873-923. doi: 10.1161/01.STR.0000223048.70103.F1. Circulation. 2006. PMID: 16785347
-
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2012 Jul;43(7):1998-2027. doi: 10.1161/STR.0b013e31825bcdac. Epub 2012 May 24. Stroke. 2012. PMID: 22627990
-
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22. Stroke. 2016. PMID: 26696642 Review.
-
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Stroke. 2011 Sep;42(9):2672-713. doi: 10.1161/STR.0b013e3182299496. Epub 2011 Jul 21. Stroke. 2011. PMID: 21778438 Free PMC article. Review.
Cited by
-
Study on pyroptosis-related genes Casp8, Gsdmd and Trem2 in mice with cerebral infarction.PeerJ. 2024 Feb 9;12:e16818. doi: 10.7717/peerj.16818. eCollection 2024. PeerJ. 2024. PMID: 38348100 Free PMC article.
-
Analysis of electrical and mechanical left atrial properties in patients with persistent atrial fibrillation.Int J Cardiovasc Imaging. 2013 Jan;29(1):71-8. doi: 10.1007/s10554-012-0053-1. Epub 2012 Apr 29. Int J Cardiovasc Imaging. 2013. PMID: 22543570
-
Current understanding of TRPM7 pharmacology and drug development for stroke.Acta Pharmacol Sin. 2013 Jan;34(1):10-6. doi: 10.1038/aps.2012.94. Epub 2012 Jul 23. Acta Pharmacol Sin. 2013. PMID: 22820907 Free PMC article. Review.
-
Construction and validation of a risk prediction model for 3- and 5-year new-onset atrial fibrillation in HFpEF patients.Front Cardiovasc Med. 2024 Aug 16;11:1429431. doi: 10.3389/fcvm.2024.1429431. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39221425 Free PMC article.
-
Relationship between left atrial appendage emptying and left atrial function using cardiac magnetic resonance in patients with atrial fibrillation: comparison with transesophageal echocardiography.Int J Cardiovasc Imaging. 2016 Jun;32 Suppl 1:163-71. doi: 10.1007/s10554-016-0893-1. Epub 2016 Apr 27. Int J Cardiovasc Imaging. 2016. PMID: 27119163
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous